Continue reading this on our app for a better experience

Open in App
Floating Button
Home News New appointments

IX Biopharma appoints Eva Tan as CCO

Lim Hui Jie
Lim Hui Jie • 1 min read
IX Biopharma appoints Eva Tan as CCO
Speciality pharmaceutical company iX Biopharma has appointed Eva Tan as its new chief commercial officer.
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Speciality pharmaceutical company iX Biopharma has appointed Eva Tan as its new chief commercial officer.

Tan previously served as iX Biopharma’s director of corporate and commercial strategy since 2019, and commercial director from 2017 to 2019.

As director of corporate and commercial strategy, Tan developed, communicated and executed corporate and commercial strategic initiatives of the iX Group.


SEE: iX Biopharma obtains approval and registration of male erectile dysfunction drug in Singapore

According to iX Biopharma’s website, Tan was a corporate lawyer at Wong Partnership prior to joining iX Biopharma, where she specialised in the capital markets practice.

She was involved in numerous local and international IPOs, including the listing of iX Biopharma Ltd on the SGX Catalist in 2015.

See also: OCBC China appoints Seth Tan new head of corporate banking

She has also had extensive experience advising on a broad range of local and cross border mergers and acquisitions and other corporate transactions.

Shares of iX Biopharma closed at 26 cents on 18 Jan, 1 cent higher than the day before.

Highlights

Re test Testing QA Spotlight
1000th issue

Re test Testing QA Spotlight

Get the latest news updates in your mailbox
Never miss out on important financial news and get daily updates today
×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.